H-CYTE, Inc. (OTCMKTS:HCYTD – Get Free Report)’s share price traded down 49.5% during trading on Friday . The company traded as low as $2.02 and last traded at $2.02. 400 shares changed hands during trading, an increase of 288% from the average session volume of 103 shares. The stock had previously closed at $4.00.
H-CYTE Trading Down 49.5 %
The business has a 50-day moving average of $2.02 and a 200 day moving average of $2.02.
About H-CYTE
H-CYTE, Inc, a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease.
Further Reading
- Five stocks we like better than H-CYTE
- What is a Bond Market Holiday? How to Invest and Trade
- FedEx Delivers Another Crushing Blow to Its Stock Price
- How to Most Effectively Use the MarketBeat Earnings Screener
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- 3 Warren Buffett Stocks to Buy Now
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for H-CYTE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H-CYTE and related companies with MarketBeat.com's FREE daily email newsletter.
